In 2017, the Commission worked in partnership with the Australasian Society of Infectious Diseases, Australasian College of Infection Prevention and Control, Public Health Laboratory Network and Australasian Society of Antimicrobials to update recommendations for the management and testing of patients with carbapenemase-producing Enterobacteriaceae (CPE). Subsequently, taxonomic studies have narrowed the definition of the family Enterobacteriaceae. Some previous members of this family are now included in other families within the order Enterobacterales, and this term is now used in many publications (ie carbapenemase-producing Enterobacterales).
The Commission’s CPE Guide is divided into 5 sections: Planning, preparation and prevention; CPE screening and surveillance; Strategies to reduce CPE transmission; Outbreak management; and Laboratory screening and confirmation methods. The Guide includes recommendations for patient management consistent with the 2010 version of the Australian Guidelines for the Prevention and Control of Infection in Healthcare.
The following supporting information and resources have also been developed: